Health Affairs

Share

Health Affairs

 •  August 10

In mid-July, the nonpartisan research arm of the federal government, the Government Accountability Office (GAO), released its long-awaited verdict on how the Food and Drug Administration (FDA) is handling compassionate use. As anyone who saw Dallas Buyers Club knows, compassionate use (also known as pre-approval access and expanded access) is when...

Health Affairs

 •  June 20

On Tuesday, June 13, the Senate Health, Education, Labor, & Pensions (HELP) Committee held the first of three planned hearings on high drug prices. This hearing, titled “How the Drug Delivery System Affects What Patients Pay,” was designed to elicit basic information about how drug prices, overall spending, and patient costs have changed over time,...

Health Affairs

 •  May 12

On March 29, 2017, senior Democrats introduced comprehensive legislation (titled the Improving Access to Affordable Prescription Drugs Act) in the House and Senate aimed at lowering prescription drug costs and improving transparency. The 129-page bill contains several popular provisions that could help drive its passage or could reappear in a...